Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -663.38% is 151% below its 5-year average of -264.53%, near the low end of its 5-year range (-663.38%–-6.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 54.34% below its 12-month average of -429.82%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -663.38%.
RETURN ON EQUITY (ROE)
-663.38%
RETURN ON EQUITY (ROE) AVG TTM
-429.82%
RETURN ON EQUITY (ROE) AVG 3Y
-271.16%
RETURN ON EQUITY (ROE) AVG 5Y
-264.53%
RETURN ON EQUITY (ROE) AVG 10Y
-141.19%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-54.34%
CURRENT VS 3Y AVG
-144.64%
CURRENT VS 5Y AVG
-150.78%
CURRENT VS 10Y AVG
-369.85%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.15%
median of 341 covered companies
CURRENT VS SECTOR MEDIAN
-2175.76%
vs the sector median at left
Cibus, Inc.
Market Cap
$128.24M
Return on Equity (ROE)
-663.38%
TTM Avg
-429.82%
3Y Avg
-271.16%
5Y Avg
-264.53%
Market Cap
$129.14M
Return on Equity (ROE)
-234.42%
TTM Avg
-102.69%
3Y Avg
-100.55%
5Y Avg
-100.92%
Market Cap
$125.27M
Return on Equity (ROE)
-2.13%
TTM Avg
-45.09%
3Y Avg
-61.80%
5Y Avg
-44.27%
Market Cap
$134.74M
Return on Equity (ROE)
-11.20%
TTM Avg
-11.86%
3Y Avg
-12.45%
5Y Avg
-5.17%
Market Cap
$118.63M
Return on Equity (ROE)
-5.10%
TTM Avg
-4.24%
3Y Avg
-6.16%
5Y Avg
0.09%
Market Cap
$118.02M
Return on Equity (ROE)
-105.40%
TTM Avg
-90.09%
3Y Avg
-60.23%
5Y Avg
-18.64%
Market Cap
$117.43M
Return on Equity (ROE)
N/A
TTM Avg
129.36%
3Y Avg
-24207.46%
5Y Avg
-16163.58%
Market Cap
$142.11M
Return on Equity (ROE)
-44.26%
TTM Avg
-34.18%
3Y Avg
285.39%
5Y Avg
-5868.11%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $128.24M | -663.38% | -429.82% | -271.16% | -264.53% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -234.42% | -102.69% | -100.55% | -100.92% |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | -2.13% | -45.09% | -61.80% | -44.27% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -11.20% | -11.86% | -12.45% | -5.17% |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $118.63M | -5.10% | -4.24% | -6.16% | 0.09% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -105.40% | -90.09% | -60.23% | -18.64% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | N/A | 129.36% | -24207.46% | -16163.58% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -44.26% | -34.18% | 285.39% | -5868.11% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | -93.44% | -8.16% | 13.24% | 13.24% |
ROE
-663.4%
ROA
-31.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -663.38% |
| 2026-03-31 | -285.85% |
| 2025-12-31 | -582.18% |
| 2025-09-30 | -235.91% |
| 2025-06-30 | -381.75% |
| 2025-03-31 | -391.10% |
| 2024-12-31 | -272.78% |
| 2024-09-30 | -402.70% |
| 2024-06-30 | -104.23% |
| 2024-03-31 | -99.11% |
| 2023-12-31 | -87.81% |
| 2023-09-30 | -11.51% |
| 2023-06-30 | -6.79% |
| 2023-03-31 | -624.90% |
| 2022-12-31 | -233.53% |
| 2022-09-30 | -238.70% |
| 2022-06-30 | -163.30% |
| 2022-03-31 | -166.14% |
| 2021-12-31 | -206.62% |
| 2021-09-30 | -224.56% |
| 2021-06-30 | -172.20% |
| 2021-03-31 | -171.06% |
| 2020-12-31 | -121.59% |
| 2020-09-30 | -124.96% |
| 2020-06-30 | -102.86% |
| 2020-03-31 | -82.42% |
| 2019-12-31 | -63.37% |
| 2019-09-30 | -49.79% |
| 2019-06-30 | -40.81% |
| 2019-03-31 | -35.23% |
| 2018-12-31 | -29.87% |
| 2018-09-30 | -26.22% |
| 2018-06-30 | -29.84% |
| 2018-03-31 | -51.09% |
| 2017-12-31 | -45.20% |
| 2017-09-30 | -38.13% |
| 2017-06-30 | -175.20% |
| 2017-03-31 | -118.50% |
| 2016-12-31 | -92.13% |
